The 6th Antigen-Specific Immune Tolerance Summit returns as the definitive industry-dedicated forum bringing you the latest discoveries, preclinical, translational, and early clinical developments on tolerogenic therapies.
Immune tolerance is not only the most dramatic and therapeutically advantageous approach in the industry's arsenal against autoimmunity; it is also transforming the biologic and gene therapy landscape through reducing ADA formation and paving the way for the industry to make multiple, lower doses while achieving greater effects.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our